Effects of Saccharomyces boulardii in <font color="blue">children_6</font> <font color="blue">with_6</font> <font color="blue">acute_6</font> <font color="blue">diarrhoea_6</font> <font color="blue">._6</font> 
<br>
<br> AIM Certain probiotic agents , e.g. Lactobacillus GG , have shown efficacy in clinical trials for the treatment of <font color="blue">acute_1</font> <font color="blue">childhood_1</font> <font color="blue">diarrhoea_1</font> <font color="blue">,_1</font> but few studies have examined the effect of Saccharomyces boulardii . We evaluated the effect of S. boulardii in <font color="blue">children_4</font> <font color="blue">with_4</font> <font color="blue">acute_4</font> <font color="blue">diarrhoea_4</font> <font color="blue">._4</font> 
<br> METHODS <font color="blue">Two_7</font> <font color="blue">hundred_7</font> <font color="blue">children_7</font> <font color="blue">were_3</font> <font color="blue">randomized_3</font> <font color="blue">to_1</font> <font color="blue">receive_1</font> <font color="blue">S._1</font> <font color="blue">boulardii_1</font> <font color="blue">in_1</font> <font color="blue">a_1</font> <font color="blue">granulated_1</font> <font color="blue">form_1</font> <font color="blue">in_1</font> <font color="blue">a_1</font> <font color="blue">daily_1</font> <font color="blue">dose_1</font> <font color="blue">of_1</font> <font color="blue">250_1</font> <font color="blue">mg_1</font> <font color="blue">(_1</font> <font color="blue">S._1</font> <font color="blue">boulardii_1</font> <font color="blue">group_1</font> <font color="blue">)_1</font> <font color="blue">or_1</font> <font color="blue">placebo_1</font> <font color="blue">(_1</font> <font color="blue">placebo_1</font> <font color="blue">group_1</font> <font color="blue">)_1</font> <font color="blue">for_1</font> <font color="blue">5_1</font> <font color="blue">d._1</font> <font color="blue">Clinical_1</font> <font color="blue">and_1</font> <font color="blue">demographic_1</font> <font color="blue">characteristics_1</font> <font color="blue">on_1</font> <font color="blue">admission_1</font> <font color="blue">were_1</font> <font color="blue">similar_1</font> <font color="blue">between_1</font> <font color="blue">the_1</font> <font color="blue">study_1</font> <font color="blue">groups_1</font> <font color="blue">._1</font> 
<br> RESULTS The medians of the average stool frequency after the second day of the treatment were significantly lower in the S. boulardii group than in the placebo group ( p = 0.003 ) . The duration of diarrhoea significantly reduced in the S. boulardii group compared with the placebo group ( 4.7 vs 5.5 d , p = 0.03 ) . The effect of S. boulardii on watery diarrhoea became apparent after the second day of the treatment . The duration of hospital stay was shorter in the S. boulardii group than in the placebo group ( 2.9 vs 3.9 d , p < 0.001 ) . Four children from the placebo group versus only one child from the S. boulardii group had persisting diarrhoea . 
<br> CONCLUSION The placebo - controlled study suggested that S. boulardii significantly reduced the duration of acute diarrhoea and the duration of hospital stay . S. boulardii seems to be a promising agent for the amelioration of the course of <font color="blue">acute_2</font> <font color="blue">diarrhoea_2</font> <font color="blue">in_2</font> <font color="blue">children_2</font> when used therapeutically .